Modern Diagnostic & Research Centre Ltd
Incorporated in 1985, Modern Diagnostic & Research Centre Ltd is in the business of providing Pathology and Radiology Services[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Healthcare Service Provider
Part of BSE SME IPO
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|
| B2B Revenue Mix % ・Standalone data |
|
|||
| Haryana Revenue Share (Domestic) % ・Standalone data |
||||
| Number of Patients Served Unit ・Standalone data |
||||
| Number of Tests Unit ・Standalone data |
||||
| Pathology Revenue Mix % ・Standalone data |
||||
| Tests per Patient Tests/Patient ・Standalone data |
||||
| Number of States of Operation States ・Standalone data |
||||
| Total Diagnostic Network Centres Centres ・Standalone data |
||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Certificate under Regulation 74(5) for the half year ended September 30, 2026
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
-
Shareholder Meeting / Postal Ballot-Outcome of AGM
- 14th AGM held on 30 Sep 2026; members approved financials, director reappointment, and auditor reappointment.
-
Closure of Trading Window
- Trading window closed from 1 October 2026 until 48 hours after half-year results submission.
-
Clarification On Significant Movement In The Price Of The Securities Of The Company
- On 15 Sep 2026, company said no UPSI or undisclosed event explains recent price movement.
Business Overview:[1][2]
a) MDRCL provides evidence-based, technology-enabled healthcare diagnostics.
b) It provides diagnostic and pathology services to individuals, health care institutions, doctors, corporates and other institutional customers.
c) Company operates through a network
of laboratories, diagnostic centres, collection centres and/or home-collection facilities.
Its hub and-spoke operating model enable centralised processing of samples while providing convenient access to customers across multiple geographies.
d) The company has 25 operational laboratories and diagnostic centres as of FY26